Comorbidity in panic disorder: II. Chronology of appearance and pathogenic comorbidity.

Comorbidity in panic disorder: II. Chronology of appearance and pathogenic comorbidity. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Comorbidity in panic disorder: II. Chronology of appearance and pathogenic comorbidity. Abstract Text:

Ages of onset and the sequence of appearance of panic disorder (PD) and comorbid conditions were determined in a sample of 54 patients with the principal DSM-III-R diagnosis of PD. The onset of PD was earlier in patients with moderate to severe agoraphobia (AG) than in panic patients without AG. Patients with alcohol abuse and drug abuse before the onset of PD also had a tendency to develop PD earlier, which suggests that these conditions might have specifically predisposed to PD. All comorbid disorders, except for major depression, were more likely to precede the onset of PD so that, more often than not, PD appeared as a chronologically secondary condition. However, it was found that only for primary substance abuse such a temporal relationship might denote etiologic relatedness to PD, because of the reduced temporal distance between the onset of primary substance abuse and secondary PD.

Comorbidity in panic disorder: II. Chronology of appearance and pathogenic comorbidity. Publishing Authors By Initials

For similar disorders of environmental origin: substance-related disorders research abstracts see: disorders of environmental origin: substance-related disorders research

PUBMED ID PMID:

MEDLINE DATE:

Comorbidity in panic disorder: II. Chronology of appearance and pathogenic comorbidity. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Psychiatry research

VOLUME: 46

Page Numbers: 285-93

Journal Abbreviation: Psychiatry Res

ISSN: 0165-1781

DAY: 17

MONTH: Mar

YEAR: 1993

Comorbidity in panic disorder: II. Chronology of appearance and pathogenic comorbidity. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7911385

Comorbidity in panic disorder: II. Chronology of appearance and pathogenic comorbidity. Keywords Mesh Terms:

KEYWORDS: Substance-Related Disorders

MESH TERMS: psychology

Chemical & Substance for Abstract: Comorbidity in panic disorder: II. Chronology of appearance and pathogenic comorbidity. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Comorbidity in panic disorder: II. Chronology of appearance and pathogenic comorbidity.

AFFILIATION: Department of Psychiatry, University of New Mexico School of Medicine, Albuquerque 87131.

Country: IRELAND

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Psychiatry Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Comorbidity in panic disorder: II Chronology of appearance and pathogenic comorbidity Related Publications

• ATRA promotes alpha tocopherol succinate-induced apoptosis in freshly isolated leukemic cells from chronic myeloid leukemic patients.
• An assessment of overall impact of family planning programme in India.
• Case report. Stones in the diverticulum of the female urethra.
• Columbianadin: A Novel Coumarin from Heracleum brunonis.
• Comorbidity in panic disorder: II. Chronology of appearance and pathogenic comorbidity.
• Determination of the ex vivo rates of human immunodeficiency virus type 1 reverse transcription by using novel strand-specific amplification analysis.
• Diastereoselective Michael Initiated Ring Closure on Vinyl Sulfone-Modified Carbohydrates: A Stereospecific and General Route to alpha-Substituted Cyclopropanes.
• Erythropoietic protoporphyria presenting in adulthood.
• Essential metal status, prooxidant/antioxidant effects of MiADMSA in male rats: age-related effects.
• Haemagglutination, haemolysin production and serum resistance of proteus and related species isolated from clinical sources.
• Historical aspects of methoxsalen and other furocoumarins.
• Hydroquinone and psoralens in the therapy of hypermelanosis and vitiligo.
• Intra-amniotic saline induction for termination of early pregnancy.
• Invertogram in a baby with imperforate anus and esophageal atresia.
• Malaria vaccine: a current perspective.
• New therapy for polymorphous light eruption.
• Oligomannan synthesis using ionic liquid supported glycosylation.
• Optimizing delivery of flurbiprofen to the colon using a targeted prodrug approach.
• Patients' adherence to osteoporosis therapy: exploring the perceptions of postmenopausal women.
• Patterns of comorbidity in panic disorder and agoraphobia.
• Photochemotherapy of vitiligo. Use of orally administered psoralens and a high-intensity long-wave ultraviolet light system.
• Post-partum sterilization.
• Prone cross-table lateral view: an alternative to the invertogram in imperforate anus.
• Retinoic acid syndrome after first dose of ATRA and ileal perforation secondary to promyelocytes infiltration.
• Rosai Dorfman syndrome with extranodal manifestation.
• Studies on the synthesis and unusual behavior of vinyl sulfone-modified hexenopyranosylthymines.
• Teaching physical diagnosis in the nursing home.
• Thanatophoric dwarfism: A report of three cases.
• The component acids of some seal blubber and liver fats.
• Water clusters (H(2)O)(n), n=6-8, in external electric fields.